2024 Q2 Form 10-Q Financial Statement

#000183537824000058 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $37.95M $36.74M $30.49M
YoY Change 9.86% 20.51% 17.88%
Cost Of Revenue $9.097M $8.732M $8.265M
YoY Change 5.89% 5.65% 30.28%
Gross Profit $28.85M $28.01M $22.22M
YoY Change 11.17% 26.04% 13.84%
Gross Profit Margin 76.03% 76.23% 72.89%
Selling, General & Admin $21.51M $22.16M $21.29M
YoY Change 5.53% 4.11% -3.18%
% of Gross Profit 74.55% 79.13% 95.8%
Research & Development $7.304M $6.321M $7.117M
YoY Change 6.22% -11.18% -2.89%
% of Gross Profit 25.31% 22.57% 32.03%
Depreciation & Amortization $2.831M $2.624M $2.030M
YoY Change 37.16% 29.26% 201.63%
% of Gross Profit 9.81% 9.37% 9.14%
Operating Expenses $28.82M $28.48M $28.40M
YoY Change 5.71% 0.27% -3.11%
Operating Profit -$2.793M -$3.100M -$8.214M
YoY Change -84.37% -62.26% -16.16%
Interest Expense $78.00K $42.00K $2.475M
YoY Change -68.55% -98.3% 7.1%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.715M -$3.058M -$5.739M
YoY Change -84.59% -46.72% -23.34%
Income Tax $7.800M $3.200M $2.824M
% Of Pretax Income
Net Earnings -$10.54M -$6.234M -$8.563M
YoY Change -44.4% -27.2% 14.96%
Net Earnings / Revenue -27.78% -16.97% -28.09%
Basic Earnings Per Share -$0.07 -$0.04 -$0.06
Diluted Earnings Per Share -$0.07 -$0.04 -$0.06
COMMON SHARES
Basic Shares Outstanding 144.4M shares 141.8M shares 136.3M shares
Diluted Shares Outstanding 144.8M shares 142.4M shares 136.0M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.58M $31.57M $45.02M
YoY Change -29.51% -29.86% -0.94%
Cash & Equivalents $30.58M $31.57M $45.02M
Short-Term Investments
Other Short-Term Assets $5.375M $6.099M $5.692M
YoY Change 30.37% 7.15% -13.38%
Inventory
Prepaid Expenses
Receivables $45.76M $41.81M $39.95M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $81.72M $79.49M $90.65M
YoY Change -9.95% -12.32% -0.14%
LONG-TERM ASSETS
Property, Plant & Equipment $20.45M $19.61M $16.97M
YoY Change 7.86% 15.59% 157.13%
Goodwill $102.5M $102.5M $117.0M
YoY Change 0.0% -12.4% 20.34%
Intangibles $22.31M $23.31M $28.79M
YoY Change -19.34% -19.01% -51.42%
Long-Term Investments $265.0K
YoY Change -12.54%
Other Assets $799.0K $1.055M $813.0K
YoY Change -4.2% 29.77% 50.0%
Total Long-Term Assets $157.5M $158.0M $166.7M
YoY Change 3.22% -5.19% -0.71%
TOTAL ASSETS
Total Short-Term Assets $81.72M $79.49M $90.65M
Total Long-Term Assets $157.5M $158.0M $166.7M
Total Assets $239.2M $237.5M $257.3M
YoY Change -1.69% -7.7% -0.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.548M $1.527M $4.919M
YoY Change 48.11% -68.96% 29.75%
Accrued Expenses $11.85M $10.84M $7.166M
YoY Change 128.13% 51.2% 71.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $29.06M $24.61M $23.84M
YoY Change 30.94% 3.23% -7.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $20.00M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $10.54M $7.833M $8.024M
YoY Change 11.36% -2.38% -23.37%
Total Long-Term Liabilities $10.54M $7.833M $30.96M
YoY Change -66.62% -74.7% 3.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.06M $24.61M $23.84M
Total Long-Term Liabilities $10.54M $7.833M $30.96M
Total Liabilities $39.60M $32.45M $54.80M
YoY Change -26.34% -40.79% -1.65%
SHAREHOLDERS EQUITY
Retained Earnings -$199.6M -$189.0M -$159.4M
YoY Change 11.86% 18.55% 13.95%
Common Stock $14.00K $13.00K $13.00K
YoY Change 7.69% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $188.9M $193.9M $202.5M
YoY Change
Total Liabilities & Shareholders Equity $239.2M $237.5M $257.3M
YoY Change -1.69% -7.7% -0.51%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$10.54M -$6.234M -$8.563M
YoY Change -44.4% -27.2% 14.96%
Depreciation, Depletion And Amortization $2.831M $2.624M $2.030M
YoY Change 37.16% 29.26% 201.63%
Cash From Operating Activities $1.234M $4.652M $368.0K
YoY Change 112.76% 1164.13% -105.1%
INVESTING ACTIVITIES
Capital Expenditures $2.326M $272.0K $89.00K
YoY Change -10.54% 205.62% -8.25%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $218.0K -$53.00K $10.01M
YoY Change 990.0% -100.53% -110.05%
Cash From Investing Activities -$2.108M -$2.594M $6.827M
YoY Change -18.29% -138.0% -106.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $20.00M $5.000M
YoY Change 300.0%
Cash From Financing Activities 37.00K -$19.96M $250.0K
YoY Change -89.84% -8082.8% -109.2%
NET CHANGE
Cash From Operating Activities 1.234M $4.652M $368.0K
Cash From Investing Activities -2.108M -$2.594M $6.827M
Cash From Financing Activities 37.00K -$19.96M $250.0K
Net Change In Cash -837.0K -$17.99M $7.445M
YoY Change -48.84% -341.63% -106.69%
FREE CASH FLOW
Cash From Operating Activities $1.234M $4.652M $368.0K
Capital Expenditures $2.326M $272.0K $89.00K
Free Cash Flow -$1.092M $4.380M $279.0K
YoY Change -45.94% 1469.89% -103.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://www.innovid.com/20240331#WarrantLiabilityNoncurrent
CY2023Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://www.innovid.com/20240331#WarrantLiabilityNoncurrent
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141194179 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141194179 shares
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
8732000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
8265000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6321000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7117000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11626000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11637000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10535000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9650000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2624000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2030000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3100000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8214000 usd
CY2024Q1 ctv Finance Expenses Income Net
FinanceExpensesIncomeNet
-42000 usd
CY2023Q1 ctv Finance Expenses Income Net
FinanceExpensesIncomeNet
-2475000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3058000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5739000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3176000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2824000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6234000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8563000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142376026 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142376026 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136008998 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136008998 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
205928000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4897000 usd
CY2023Q1 ctv Share Based Compensation Arrangement By Share Based Payment Award Stock Options Exercised And Restricted Stock Units Vested In Period Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodValue
250000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8563000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
202512000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
195990000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4118000 usd
CY2024Q1 ctv Share Based Compensation Arrangement By Share Based Payment Award Stock Options Exercised And Restricted Stock Units Vested In Period Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodValue
43000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6234000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
193917000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6234000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8563000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2624000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2030000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3838000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4533000 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
204000 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2714000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-90000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4606000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3708000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
201000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2922000 usd
CY2024Q1 ctv Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
376000 usd
CY2023Q1 ctv Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
459000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1282000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1558000 usd
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2736000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-299000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-347000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-584000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3714000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3162000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4652000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
368000 usd
CY2024Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2269000 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3091000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
272000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
89000 usd
CY2024Q1 ctv Withdrawal Of Short Term Bank Deposits
WithdrawalOfShortTermBankDeposits
0 usd
CY2023Q1 ctv Withdrawal Of Short Term Bank Deposits
WithdrawalOfShortTermBankDeposits
-10000000 usd
CY2024Q1 ctv Proceeds From Payments For Deposits Investing Activities
ProceedsFromPaymentsForDepositsInvestingActivities
-53000 usd
CY2023Q1 ctv Proceeds From Payments For Deposits Investing Activities
ProceedsFromPaymentsForDepositsInvestingActivities
7000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2594000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6827000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
20000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5000000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
43000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
250000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19957000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
250000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-90000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17989000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7445000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49997000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37971000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32008000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45416000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
681000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
203000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
68000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
362000 usd
CY2024Q1 ctv Right Of Use Assets Obtained In Exchange For Operating Lease Liabilitie Upon Lease Modification
RightOfUseAssetsObtainedInExchangeForOperatingLeaseLiabilitieUponLeaseModification
10071000 usd
CY2023Q1 ctv Right Of Use Assets Obtained In Exchange For Operating Lease Liabilitie Upon Lease Modification
RightOfUseAssetsObtainedInExchangeForOperatingLeaseLiabilitieUponLeaseModification
0 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31574000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45015000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
434000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
401000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32008000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45416000 usd
CY2024Q1 ctv Revenue From Contract With Customer Payment Term
RevenueFromContractWithCustomerPaymentTerm
P60D
CY2024Q1 ctv Revenue Recognition Advertisement Serving Services Percentage
RevenueRecognitionAdvertisementServingServicesPercentage
0.753
CY2023Q1 ctv Revenue Recognition Advertisement Serving Services Percentage
RevenueRecognitionAdvertisementServingServicesPercentage
0.730
CY2024Q1 ctv Revenue Recognition Measurement Serving Percentage
RevenueRecognitionMeasurementServingPercentage
0.212
CY2023Q1 ctv Revenue Recognition Measurement Serving Percentage
RevenueRecognitionMeasurementServingPercentage
0.230
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of the condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates, judgments, and assumptions that affect the amounts reported in the financial statements. The results for interim periods are not necessarily indicative of results to be expected for the year or for any future periods. In management’s opinion, these unaudited condensed consolidated interim financial statements contain all adjustments of a normal recurring nature necessary for a fair presentation of the financial statements for the interim period presented based upon information available at the time they are made. Actual results could differ from those estimates.
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prior Period Reclassification</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in prior year’s condensed consolidated balance sheet have been reclassified to conform to current year’s presentation.</span></div>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risk</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net. The majority of the Company’s cash and cash equivalents are invested in deposits with major banks in the US, Israel and UK. The Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed insured limits. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.</span></div>The Company’s trade receivables, net is mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing ongoing credit evaluations of its customers’ financial conditions. The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
CY2024Q1 ctv Revenue Recognition Creative Serving Percentage
RevenueRecognitionCreativeServingPercentage
0.030
CY2023Q1 ctv Revenue Recognition Creative Serving Percentage
RevenueRecognitionCreativeServingPercentage
0.039
CY2024Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2024Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingunit
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2099000 usd
CY2024Q1 ctv Capitalized Commission Costs
CapitalizedCommissionCosts
0 usd
CY2023 ctv Capitalized Commission Costs
CapitalizedCommissionCosts
0 usd
CY2024Q1 us-gaap Lessor Operating Lease Renewal Term
LessorOperatingLeaseRenewalTerm
P5Y
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11129000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
11558000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1435000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1834000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
496000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
463000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
270000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
263000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
38000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
21000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
804000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
747000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y8M12D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.072
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
441000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
523000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1249000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
986000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1508000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1538000 usd
CY2024Q1 ctv Lessee Operating Lease Liability To Be Paid Year After Four
LesseeOperatingLeaseLiabilityToBePaidYearAfterFour
9899000 usd
CY2024Q1 ctv Lessee Operating Lease Liability Undiscounted Lease Payments
LesseeOperatingLeaseLiabilityUndiscountedLeasePayments
17279000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5721000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11558000 usd
CY2022Q3 ctv Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2 subsidiary
CY2024Q1 ctv Bank Guarantees In Connection With Office Lease Agreement
BankGuaranteesInConnectionWithOfficeLeaseAgreement
200000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2100000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
400000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
300000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3200000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2800000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.039
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.492
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36738000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30485000 usd
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
30742000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
19854000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001835378-24-000058-index-headers.html Edgar Link pending
0001835378-24-000058-index.html Edgar Link pending
0001835378-24-000058.txt Edgar Link pending
0001835378-24-000058-xbrl.zip Edgar Link pending
ctv-20240331.htm Edgar Link pending
ctv-20240331.xsd Edgar Link pending
exhibit311q12024.htm Edgar Link pending
exhibit312q12024.htm Edgar Link pending
exhibit321q12024.htm Edgar Link pending
exhibit322q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
ctv-20240331_cal.xml Edgar Link unprocessable
ctv-20240331_def.xml Edgar Link unprocessable
ctv-20240331_htm.xml Edgar Link completed
ctv-20240331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctv-20240331_pre.xml Edgar Link unprocessable